Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SIGA Technologies Inc (OTC Pink - Current Information:SIGAQ)

1.32
Delayed Data
As of Aug 28
 0.00 / 0.00%
Today’s Change
0.99
Today|||52-Week Range
2.68
-8.33%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$71.1M

Company Description

SIGA Technologies, Inc. operates as a company specializing in the development and commercialization of solutions for serious unmet medical needs and bio threats. The company specializes in developing therapeutic solutions for some of the most lethal pathogens, which include smallpox, Ebola, dengue, Lassa fever and other dangerous viruses. Its product Arestvyr also known as ST-246, is an orally administered antiviral drug that targets orthopoxviruses. SIGA Technologies was founded on December 28, 1995 and is headquartered in New York, NY.

Contact Information

SIGA Technologies, Inc.
660 Madison Avenue
New York New York 10065
P:(212) 672-9100
Investor Relations:

Employees

Shareholders

Individual stakeholders33.94%
Other institutional10.24%
Mutual fund holders0.19%

Top Executives

Eric A. RoseChairman & Chief Executive Officer
Daniel J. LuckshireChief Financial Officer, Secretary & Executive VP
Dennis E. HrubyChief Scientific Officer & Vice President
William J. HaynesExecutive Vice President & General Counsel
Akhila KosarajuVice President-Global Development